Status:
ACTIVE_NOT_RECRUITING
Methionine PET/CT Studies In Patients With Cancer
Lead Sponsor:
St. Jude Children's Research Hospital
Conditions:
Brain Tumors and/or Solid Tumors Including
Brain Stem Glioma
Eligibility:
All Genders
Phase:
PHASE2
Brief Summary
The purpose of this study is to test the usefulness of imaging with radiolabeled methionine in the evaluation of children and young adults with tumor(s). Methionine is a naturally occurring essential ...
Detailed Description
The study focuses on the following objectives: Primary objective: * To estimate the success rate of Methionine (MET) for visualizing tumors at the time of diagnosis. The study hypothesizes that at l...
Eligibility Criteria
Inclusion
- All participants under the care of St. Jude physicians with known or suspected neoplastic disease are eligible for participation.
- Participants will have had, or are scheduled to have clinical imaging evaluations which may include FDG PET CT, or CT, or MRI within 4 weeks of entry.
- No limit on age or gender.
- Female participants of childbearing age must not be lactating due to theoretical potential harm to the infant from exposure to radiation.
- Informed consent signed by participant, parent, or guardian according to the guidelines of the institutional review board.
Exclusion
- More than 6 MET PET scans within the previous 12 months.
- Inability or unwillingness of research participant, parent, or legal guardian/representative to give written informed consent.
- Inclusion Criteria for Open-Access
- All participants under the care of St. Jude physicians with known or suspected neoplastic disease are eligible for participation.
- No limit on age or gender
- Female participants of childbearing age must not be lactating due to theoretical potential harm to the infant from exposure to radiation.
- Informed consent signed by participant, parent, or guardian according to the guidelines of the institutional review board.
- Exclusion Criteria for Open-Access
- More than 6 MET PET scans within the previous 12 months.
- Inability or unwillingness of research participant, parent, or legal guardian/representative to give written informed consent.
Key Trial Info
Start Date :
July 20 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 27 2027
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT00840047
Start Date
July 20 2009
End Date
July 27 2027
Last Update
February 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38119